$10.25
12.02% day before yesterday
Nasdaq, May 16, 10:14 pm CET
ISIN
CA35954B2066
Symbol
QNTM

FSD Pharma Inc Stock price

$10.25
+4.01 64.26% 1M
+5.33 108.33% 6M
+6.57 178.53% YTD
-10.23 49.94% 1Y
-47.05 82.11% 3Y
-207.50 95.29% 5Y
-1,115.95 99.09% 10Y
Nasdaq, Closing price Fri, May 16 2025
+1.10 12.02%
ISIN
CA35954B2066
Symbol
QNTM

Key metrics

Market capitalization $23.57m
Enterprise Value $17.37m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
P/B ratio (TTM) P/B ratio 4.85
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-16.99m
Free Cash Flow (TTM) Free Cash Flow $-9.02m
Cash position $6.28m
EPS (TTM) EPS $-14.82
P/S forward 2.72
EV/Sales forward 2.00
Short interest 8.53%
Show more

Is FSD Pharma Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,790 stocks worldwide.

FSD Pharma Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast FSD Pharma Inc:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast FSD Pharma Inc:

Buy
100%

Financial data from FSD Pharma Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
- -
-
100%
- Direct Costs 0.50 0.50
67% 67%
-
-0.50 -0.50
67% 67%
-
- Selling and Administrative Expenses 8.42 8.42
15% 15%
-
- Research and Development Expense 7.57 7.57
343% 343%
-
-16 -16
56% 56%
-
- Depreciation and Amortization 0.50 0.50
67% 67%
-
EBIT (Operating Income) EBIT -17 -17
41% 41%
-
Net Profit -21 -21
105% 105%
-

In millions USD.

Don't miss a Thing! We will send you all news about FSD Pharma Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

FSD Pharma Inc Stock News

Neutral
GlobeNewsWire
2 days ago
TORONTO, May 16, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) “Quantum BioPharma” or the “Company”) a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announced that management will attend the Sidoti Micro-Cap Conference and the A.G.P. Virtual Healthcare Conference in May 2025.
Neutral
GlobeNewsWire
6 days ago
TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announced that dosing of drug has completed in 90-day oral toxicity and toxicokinetic studies for Lucid-21-302 (Lucid-MS) for Multiple Sclero...
Neutral
Seeking Alpha
12 days ago
Call Start: 16:30 January 1, 0000 4:57 PM ET Quantum BioPharma Ltd. (NASDAQ:QNTM ) Business Update Conference Call May 6, 2025, 04:30 PM ET Company Participants Zeeshan Saeed - Founder, Chief Executive Officer, President and Executive Co-Chair Jason Sawyer - Head of Finance and M&A Conference Call Participants Operator Greetings, and welcome to the Quantum BioPharma Business Update Conference C...
More FSD Pharma Inc News

Company Profile

FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for various central nervous system disorders, including chronic pain, fibromyalgia, and irritable bowel syndrome. FSD Pharma Inc. has a strategic alliance agreement with SciCann Therapeutics Inc. for the production and distribution of cannabinoid-based, patent pending, and indication-specific products; and collaborative research and development agreement with Solarvest BioEnergy Inc. The company is headquartered in Cobourg, Canada.

Head office Canada
CEO Zeeshan Saeed
Employees 7
Founded 1994
Website www.quantumbiopharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today